2 Unstoppable Stocks to Buy No Matter What Happens in the Second Half of the YearThe Motley Fool • 06/30/21
Full FDA approval of Pfizer's and Moderna's COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months awayMarket Watch • 06/28/21
FDA Revises Pfizer, Moderna COVID-19 Vaccine Sheets With Rare Heart Inflammation WarningBenzinga • 06/28/21
Pfizer And Moderna Vaccines May Offer Years-Long Protection Against Covid-19, Scientists SayForbes • 06/28/21
FDA adds warning about risk of rare heart inflammation to Pfizer, Moderna Covid vaccinesCNBC • 06/26/21
Reopening Stocks Have Soared in 2021 -- but Is All the Good News Priced In?The Motley Fool • 06/26/21
Pfizer Stops Global Smoking Cessation Pill Distribution After Flagging Impurities: ReportBenzinga • 06/25/21
Transgene: First Patient Enrolled in Expanded Phase II Clinical Trial of TG4001 + Avelumab Vs Avelumab Alone in Patients With HPV16-positive Anogenital CancersBusiness Wire • 06/24/21
Moderna, Pfizer Stocks Fall After CDC Panel Flags Heart Inflammation Risk In Young Adults Receiving COVID-19 VaccineBenzinga • 06/23/21